• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性p70杀伤细胞抑制性受体与HLA - B*5101的结合:对所有三个p70免疫球蛋白结构域的需求

Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains.

作者信息

Rojo S, Wagtmann N, Long E O

机构信息

Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD 20852-1727, USA.

出版信息

Eur J Immunol. 1997 Feb;27(2):568-71. doi: 10.1002/eji.1830270231.

DOI:10.1002/eji.1830270231
PMID:9045932
Abstract

Lysis of target cells by natural killer (NK) cells can be prevented by killer cell inhibitory receptors (KIR) specific for major histocompatibility complex class I molecules. Functional studies have identified two distinct p58 KIR, each reactive with a different group of HLA-C allotypes, and distinct p70 KIR specific for some HLA-B or HLA-A allotypes. The NK specificities for each group of HLA-C allotypes have been reproduced by direct binding of recombinant soluble p58 molecules. Here, we show that a soluble p70 KIR binds to HLA-B5101, but not to HLA-A or HLA-C molecules. Truncated soluble forms of the HLA-B5101-specific p70 KIR, including one with two immunoglobulin (Ig) domains reactive with a monoclonal antibody that blocks p70 KIR function, did not bind to HLA-B*5101, indicating that all three Ig domains are required for binding.

摘要

自然杀伤(NK)细胞对靶细胞的裂解可被主要组织相容性复合体I类分子特异性的杀伤细胞抑制受体(KIR)所阻止。功能研究已鉴定出两种不同的p58 KIR,每种都与不同组的HLA - C同种异型反应,以及对某些HLA - B或HLA - A同种异型特异的不同p70 KIR。通过重组可溶性p58分子的直接结合,已重现了每组HLA - C同种异型的NK特异性。在此,我们表明可溶性p70 KIR与HLA - B5101结合,但不与HLA - A或HLA - C分子结合。HLA - B5101特异性p70 KIR的截短可溶性形式,包括一种带有两个免疫球蛋白(Ig)结构域且与阻断p70 KIR功能的单克隆抗体反应的形式,不与HLA - B*5101结合,表明结合需要所有三个Ig结构域。

相似文献

1
Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains.可溶性p70杀伤细胞抑制性受体与HLA - B*5101的结合:对所有三个p70免疫球蛋白结构域的需求
Eur J Immunol. 1997 Feb;27(2):568-71. doi: 10.1002/eji.1830270231.
2
Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.p58自然杀伤细胞抑制性受体识别HLA - C的分子基础。
J Immunol. 1997 Oct 15;159(8):3875-82.
3
Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.自然杀伤细胞抑制性受体的直接结合与功能转移揭示了HLA - C同种异型识别的新模式。
J Immunol. 1998 Jul 15;161(2):571-7.
4
Natural killer cell recognition of HLA class I molecules.自然杀伤细胞对HLA I类分子的识别。
Rev Immunogenet. 2000;2(3):433-48.
5
The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells.
J Immunol. 1995 Nov 1;155(9):4143-6.
6
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.针对HLA - A同种异型的自然杀伤细胞受体:p58 / p70抑制性受体家族的一个新成员,其特征为具有三个免疫球蛋白样结构域,并以140-kD二硫键连接的二聚体形式表达。
J Exp Med. 1996 Aug 1;184(2):505-18. doi: 10.1084/jem.184.2.505.
7
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.人类自然杀伤细胞对HLA - G的识别。CD94作为抑制性和激活性受体复合物的参与情况。
Eur J Immunol. 1997 Aug;27(8):1875-80. doi: 10.1002/eji.1830270809.
8
Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells.与杀伤细胞抑制性受体结合的锌离子调节人类自然杀伤细胞中的负信号。
J Immunol. 1998 Aug 1;161(3):1299-305.
9
Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.人类自然杀伤细胞抑制性受体的结构类似于造血受体。
Nature. 1997 Sep 4;389(6646):96-100. doi: 10.1038/38028.
10
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.人类白细胞抗原E(HLA-E)与自然杀伤细胞受体CD94/NKG2A、B及C相结合。
Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869.

引用本文的文献

1
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma.个体遗传组成控制自然杀伤细胞功能,影响多发性骨髓瘤患者伊沙妥昔单抗免疫治疗的疗效。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002958.
2
KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis.杀伤细胞免疫球蛋白样受体/人类白细胞抗原基因型赋予自身免疫性肝炎患者易感性并促使病情进展。
JHEP Rep. 2019 Oct 25;1(5):353-360. doi: 10.1016/j.jhepr.2019.09.003. eCollection 2019 Nov.
3
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.
杀伤细胞免疫球蛋白样受体 3DL1 变异可改变 HLA-B*57 对 HIV-1 的保护作用。
J Clin Invest. 2018 May 1;128(5):1903-1912. doi: 10.1172/JCI98463. Epub 2018 Apr 3.
4
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.与HLA - Bw4 - T - 80和HLA - A - Bw4亚型相比,HLA - Bw4 - I - 80亚型在基于利妥昔单抗或地努图希单抗的癌症免疫治疗中对临床结果有不同影响。
Front Immunol. 2017 Jun 12;8:675. doi: 10.3389/fimmu.2017.00675. eCollection 2017.
5
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.杀伤细胞免疫球蛋白样受体3DL1多态性定义了HLA I类识别的不同层次结构。
J Exp Med. 2016 May 2;213(5):791-807. doi: 10.1084/jem.20152023. Epub 2016 Apr 4.
6
Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.免疫信息学对接方法分析 KIR3DL1/HLA-B 相互作用。
Biomed Res Int. 2013;2013:283805. doi: 10.1155/2013/283805. Epub 2013 Aug 1.
7
Structural insights into activation of antiviral NK cell responses.抗病毒 NK 细胞反应激活的结构见解。
Immunol Rev. 2012 Nov;250(1):239-57. doi: 10.1111/j.1600-065X.2012.01168.x.
8
Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.对 KIR3DS1*014 与 HLA 结合的分析表明 KIR3DS1 具有独特的进化史。
J Immunol. 2011 Sep 1;187(5):2162-71. doi: 10.4049/jimmunol.1002906. Epub 2011 Jul 29.
9
Variable NK cell receptors exemplified by human KIR3DL1/S1.可变 NK 细胞受体,以人类 KIR3DL1/S1 为例。
J Immunol. 2011 Jul 1;187(1):11-9. doi: 10.4049/jimmunol.0902332.
10
Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.自然杀伤细胞受体 KIR3DL1*004 与伴侣分子的相互作用以及构象特异性抗体揭示了其具有功能性折叠状态和主要的细胞内滞留。
J Immunol. 2011 Jan 1;186(1):62-72. doi: 10.4049/jimmunol.0903657. Epub 2010 Nov 29.